Doctors debate cancer risk of Vytorin, Zetia

 
Cholesterol NEWS AND VIEWS
November 17, 2008
Hundreds of heart experts attended a panel discussion at the annual meeting of the American Heart Association to debate the benefits and risks of the cholesterol drugs Vytorin and Zetia.  Read more>
This Week's News
 See all Cholesterol news
Abbott Laboratories Inc's experimental drug TriLipix was able to significantly improve cholesterol and triglyceride levels in patients for another year following earlier 3-month trials, researchers said on Tuesday.  Read more>
The American Medical Association threw its weight behind legislation to ban the use of artificial trans fats in restaurants and bakeries nationwide on Monday.  Read more>
High levels of triglycerides, a fatty molecule found in the blood, detected while a person is not fasting, are associated with an increased risk of stroke, according to analysis of data from the Copenhagen City Heart Study.  Read more>
Experts say the Internet may offer patients an easier way to have doctors review their case and provide advice.  Read more>
Find options for heart valve replacement.  Read more>
Quiz of the Week
Your risk of heart disease and heart failure are increased by a number of factors. Do you know what they are? Test your knowledge. 
Today's Poll
Do you know the symptoms of pre-diabetes?
Your options are:
  • Yes
  • No
News You Can Use
Building a relationship with your family pharmacy, asking questions about your meds, and keeping track of the drugs you're taking are all ways to get "medicine smart," experts say. Read more>

 

The HealthCentral Network, 1655 N. Fort Myer Drive, #400, Arlington, VA 22209

(c) 2008 The HealthCentral Network, Inc. All rights reserved. Privacy Policy.